13.09.2019
- Abbvie takes over Allergan, Pfizer merges its generics business with Mylan, Takeda integrates Shire — the pharmaceutical industry is making a name for itself in 2019 with several...
15.03.2017
- US activist investor Bill Ackman is pulling the plug on his Pershing Square Capital Management hedge fund’s loss-making engagement in drugmaker Valeant. After the close of trading...
30.07.2015
- July this year began with the highest-ever value of M&A transactions announced in any July since 2008, says Mergermarket, an independent Mergers and Acquisitions (M&A) intelligence...
15.06.2015
- Following shareholder approval of the name change on Jun 5, Iceland-based generic drugmaker Actavis has begun trading as Allergan. The name change follows the Botox manufacturer’s...
24.04.2015
- US-managed generics drugmaker Mylan, now domiciled in the Netherlands, is said to be preparing a "poison pill" defense to escape its pursuit by Israeli generics giant Teva. Teva...
05.03.2015
- DuPont has rejected a request from activist investor Nelson Peltz and his hedge fund Trian to use a universal ballot in an upcoming vote on candidates for the chemical producer's...
25.02.2015
- With activist investors continuing to make headlines in the chemical industry, especially in the US, the struggles of Dow, DuPont and Botox producer Allergan are cases in point -...
19.02.2015
- Three months after acquiring US Botox producer Allergan for $66 billion, Ireland-based drugmaker Actavis has announced it will adopt Allergan as the name of the merged corporate...
